
    
      656 patients diagnosed with acute cerebral ischemia disease (onsetâ‰¤7d) based on ICD-10 and
      CT/MRI criteria, who have cognitive impairment meeting all of the inclusion criteria and none
      of the exclusion criteria, will be included and randomized into nimodipine treatment group
      and the controlled group.Evaluations of cognitive function will be taken at baseline, 1
      month, 3 months, and 6 months.
    
  